Wagner, C., Roychoudhury, P., Hadfield, J., Hodcroft, E.B., Lee, J., Moncla, L.H., Müller, N.F., Behrens, C., Huang, M.L., Mathias, P. and Pepper, G. (2020) Comparing Viral Load and Clinical Outcomes in Washington State across D 614G Mutation in Spike Protein of SARS-CoV-2.
https://github.com/blab/ncov-wa-d614g

has been cited by the following article:

• TITLE: A Review on D 614G Mutation with Bangladesh Scenario

  AUTHORS: Arifa Akram, Mohammad Jahidur Rahman Khan, Md. Bayzid Bin Monir, Md. Reaz Uddin Chowdhury, Mahmuda Yeasmin, Md. Maruf Ahmed Molla, Tasnim Nafisa

  KEYWORDS: Coronavirus, D 614G Mutation, SARS-CoV-2, Spike Protein, Global Initiative for Sharing All Influenza Data (GISAID)

  JOURNAL NAME: Advances in Infectious Diseases, Vol.10 No.3, December 18, 2020

  ABSTRACT: With the COVID-19 pandemic, disparities between the infection rate and death rate in different countries become a major concern. In some countries, lower mortality rate compared to others can be explained by better testing capacity and intensive care facilities. Complete SARS-CoV-2 genome sequences from different countries of the world are continually submitted to Global Initiative for Sharing All Influenza Data using Next Generation Sequencing method. A SARS-CoV-2 variant with a D 614G Mutation in the spike (S) protein has become the most dominant form in the global pandemic. There are a number of ongoing studies trying to relate this mutation with the infectivity, mortality, transmissibility of the virus and its impact on vaccine development. This review aims to accumulate the major findings from some of these studies and focus its future implication. Some studies suggested D 614G strain has increased binding capacity, it affects more cells at a faster rate, so has a high transmissibility. Patients infected with this strain were found with high viral load. But still now there is no such evidence that this strain produces more severe disease as well as increased mortality. The structural change of spike protein produced by D 614G mutation was minor and did not hamper the vaccine efficacy. Some studies showed antibodies produced against D614 strain can neutralize G614 strain and vice versa. Whenever a mutation occurs in spike protein there are always chances of affecting the infectivity, transmissibility, vaccine efficacy. Therefore, more studies are required to find out the overall effect of D 614G mutation.